Patritumab Deruxtecan Biosimilar - Research Grade
Product Sizes
1 mg
ICH5206D-1MG
About this Product
- SKU:
- ICH5206D
- Additional Names:
- Dxd
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1 mg/ml
- Extra Details:
- Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan) is a novel ADC composed of an anti-HER3 antibody (Patritumab) and a novel potent topoisomerase I inhibitor DX-8951,conjugated, on an average of 8 cysteinyl, to deruxtecan, comprising a linker and a camptothecin derivative.
- Formulation:
- 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
- Immunogen:
- ERBB3 / HER3
- Isotype:
- IgG1
- Purity:
- >90%
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
